chr7-117595001-T-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000492.4(CFTR):​c.2562T>G​(p.Thr854Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.345 in 1,611,676 control chromosomes in the GnomAD database, including 101,808 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T854T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.43 ( 15267 hom., cov: 32)
Exomes 𝑓: 0.34 ( 86541 hom. )

Consequence

CFTR
NM_000492.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:17

Conservation

PhyloP100: 0.278

Publications

85 publications found
Variant links:
Genes affected
CFTR (HGNC:1884): (CF transmembrane conductance regulator) This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017]
CFTR Gene-Disease associations (from GenCC):
  • cystic fibrosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Orphanet
  • congenital bilateral absence of vas deferens
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary chronic pancreatitis
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 7-117595001-T-G is Benign according to our data. Variant chr7-117595001-T-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 43577.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.278 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.627 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000492.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CFTR
NM_000492.4
MANE Select
c.2562T>Gp.Thr854Thr
synonymous
Exon 15 of 27NP_000483.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CFTR
ENST00000003084.11
TSL:1 MANE Select
c.2562T>Gp.Thr854Thr
synonymous
Exon 15 of 27ENSP00000003084.6
CFTR
ENST00000699602.1
c.2562T>Gp.Thr854Thr
synonymous
Exon 15 of 27ENSP00000514471.1
CFTR
ENST00000426809.5
TSL:5
c.2472T>Gp.Thr824Thr
synonymous
Exon 14 of 26ENSP00000389119.1

Frequencies

GnomAD3 genomes
AF:
0.426
AC:
64588
AN:
151756
Hom.:
15229
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.634
Gnomad AMI
AF:
0.220
Gnomad AMR
AF:
0.413
Gnomad ASJ
AF:
0.177
Gnomad EAS
AF:
0.417
Gnomad SAS
AF:
0.418
Gnomad FIN
AF:
0.429
Gnomad MID
AF:
0.237
Gnomad NFE
AF:
0.321
Gnomad OTH
AF:
0.370
GnomAD2 exomes
AF:
0.383
AC:
96181
AN:
251152
AF XY:
0.374
show subpopulations
Gnomad AFR exome
AF:
0.646
Gnomad AMR exome
AF:
0.466
Gnomad ASJ exome
AF:
0.180
Gnomad EAS exome
AF:
0.425
Gnomad FIN exome
AF:
0.418
Gnomad NFE exome
AF:
0.320
Gnomad OTH exome
AF:
0.354
GnomAD4 exome
AF:
0.337
AC:
491244
AN:
1459802
Hom.:
86541
Cov.:
32
AF XY:
0.336
AC XY:
244394
AN XY:
726342
show subpopulations
African (AFR)
AF:
0.651
AC:
21758
AN:
33428
American (AMR)
AF:
0.457
AC:
20403
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.180
AC:
4687
AN:
26100
East Asian (EAS)
AF:
0.407
AC:
16087
AN:
39522
South Asian (SAS)
AF:
0.399
AC:
34398
AN:
86198
European-Finnish (FIN)
AF:
0.415
AC:
22123
AN:
53360
Middle Eastern (MID)
AF:
0.275
AC:
1558
AN:
5670
European-Non Finnish (NFE)
AF:
0.315
AC:
349674
AN:
1110536
Other (OTH)
AF:
0.341
AC:
20556
AN:
60302
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
15058
30116
45173
60231
75289
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11584
23168
34752
46336
57920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.426
AC:
64673
AN:
151874
Hom.:
15267
Cov.:
32
AF XY:
0.429
AC XY:
31828
AN XY:
74216
show subpopulations
African (AFR)
AF:
0.634
AC:
26239
AN:
41416
American (AMR)
AF:
0.414
AC:
6317
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.177
AC:
613
AN:
3470
East Asian (EAS)
AF:
0.417
AC:
2157
AN:
5170
South Asian (SAS)
AF:
0.418
AC:
2015
AN:
4818
European-Finnish (FIN)
AF:
0.429
AC:
4503
AN:
10508
Middle Eastern (MID)
AF:
0.231
AC:
68
AN:
294
European-Non Finnish (NFE)
AF:
0.321
AC:
21779
AN:
67918
Other (OTH)
AF:
0.371
AC:
783
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1729
3457
5186
6914
8643
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
576
1152
1728
2304
2880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.322
Hom.:
6661
Bravo
AF:
0.433
Asia WGS
AF:
0.466
AC:
1618
AN:
3468
EpiCase
AF:
0.296
EpiControl
AF:
0.290

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:17
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Dec 27, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Jan 19, 2018
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 20, 2011
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Cystic fibrosis Benign:5
Jan 29, 2018
CFTR-France
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

the variant does not result in CFTR-RD neither

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 01, 2023
Payam Genetics Center, General Welfare Department of North Khorasan Province
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Nov 19, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CFTR-related disorder Benign:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.

Mar 28, 2017
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:2
Nov 30, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Hereditary pancreatitis Benign:1
Dec 09, 2019
Sema4, Sema4
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
4.7
DANN
Benign
0.35
PhyloP100
0.28
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1042077; hg19: chr7-117235055; COSMIC: COSV50040915; API